Blood Cells Mol Dis
July 2018
Intron-22 (Inv22) and intron-1 (Inv1) inversions account for approximately one half of all severe cases of hemophilia A (SHA) worldwide. Inhibitor development against exogenous factor VIII (FVIII) represents a major complication in HA. The causative F8 mutation is considered the most decisive factor conditioning inhibitor development.
View Article and Find Full Text PDFBackground: Chronic myeloid leukemia represents 15 % of all the leukemias in adults. With the introduction of tyrosine kinase inhibitors, overall survival at 10 years is 80-90 %. The objective was to describe the epidemiology, complete cytogenetic response and major molecular response with tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
View Article and Find Full Text PDFObjective: to show clinical and therapeutic findings in patients with diagnosis of acute megakaryoblastic leukemia (AML).
Methods: twenty four patients with diagnosis AML was carried out. Clinical, laboratory survey results and treatment response were studied.